Large-conductance calcium-activated potassium channel (BK channel) (BK channel)

The Large-conductance calcium-activated potassium channel (BK channel), also known as the Maxi-K channel, is a high-conductance ion channel that is uniquely regulated by both membrane depolarization and increases in intracellular calcium concentration [1]. It serves as a critical physiological link between cellular metabolism and electrical activity, playing a major role in the repolarization of action potentials and the regulation of calcium signaling [2]. In vascular and visceral smooth muscle, BK channel activation promotes membrane hyperpolarization, leading to muscle relaxation and vasodilation, which makes it a significant target for treating hypertension and asthma [3]. Within the central nervous system, these channels are localized at presynaptic terminals and postsynaptic sites, where they modulate neurotransmitter release and neuronal firing patterns [4]. Dysfunction of the BK channel is associated with a variety of disorders, including epilepsy, chronic pain, and overactive bladder [5]. Pharmacological strategies include the development of BK channel openers to treat conditions characterized by hyperexcitability, as well as blockers for research and specific therapeutic applications [6]. However, the widespread expression of BK channels across multiple organ systems presents a significant challenge for drug development, as systemic modulation can lead to broad off-target effects [7]. Furthermore, the channel's functional properties are heavily influenced by its association with various auxiliary subunits, which vary by tissue type and add another layer of complexity to its pharmacology [8]. Sources: [1] UniProt (P13255 - KCNMA1) [2] PubMed (PMID: 24507638) [3] PubMed (PMID: 30103458) [4] PubMed (PMID: 29158315) [5] PubMed (PMID: 25634561) [6] PubChem (BMS-204352) [7] PubMed (PMID: 22403514) [8] PubMed (PMID: 31039419)

Other names

Maxi-K channelBKCaKCa1.1Slo1KCNMA1Calcium-activated potassium channel subunit alpha-1

Drugs targeting this channel typically act as either openers (activators) or blockers. Openers increase the probability of the channel being in an open state, allowing potassium efflux which leads to membrane hyperpolarization and reduced cellular excitability. Blockers inhibit the channel pore or stabilize the closed state, preventing potassium flow and maintaining or increasing cellular excitability.